Captodiame

Captodiame
	File:Captodiame.svg
Clinical data
Routes of; administration	Oral
ATC code	N05BB02 (WHO) ;
Pharmacokinetic data
Excretion	Renal
Identifiers
	IUPAC name 2-[(4-butylsulfanylphenyl)-phenyl-methyl]; sulfanyl-N,N-dimethylethanamine;
CAS Number	486-17-9;
PubChem CID	10240;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C21H29NS2
Molar mass	359.594 g/mol

Captodiame (INN, also known as captodiamine) is an anxiolytic. It is a derivative of diphenhydramine.^[1]

A 2004 study suggested captodiame may be helpful in preventing benzodiazepine withdrawal syndrome in people discontinuing benzodiazepine treatment.^[1]

References

↑ ^1.0 ^1.1 Mercier-Guyon C, Chabannes JP, Saviuc P (2004). "The role of captodiamine in the withdrawal from long-term benzodiazepine treatment". Curr Med Res Opin. 20 (9): 1347–55. doi:10.1185/030079904125004457. PMID 15383182. Free full text with registration

Clinical data
File:Captodiame.svg
Routes of administration	Oral
ATC code	N05BB02 (WHO)
Pharmacokinetic data
Excretion	Renal
Identifiers
IUPAC name 2-[(4-butylsulfanylphenyl)-phenyl-methyl] sulfanyl-N,N-dimethylethanamine
CAS Number	486-17-9
PubChem CID	10240
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₁H₂₉NS₂
Molar mass	359.594 g/mol